<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Lab resource: Multiple cell lines Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-12-18">18 December 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Viviana</forename><surname>Meraviglia</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute for Biomedicine</orgName>
								<orgName type="institution">Eurac Research</orgName>
								<address>
									<settlement>Bolzano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Affiliated Institute of the University of Lübeck</orgName>
								<address>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrizia</forename><surname>Benzoni</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sara</forename><surname>Landi</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><surname>Murano</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marianna</forename><surname>Langione</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Benedetta</forename><forename type="middle">M</forename><surname>Motta</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute for Biomedicine</orgName>
								<orgName type="institution">Eurac Research</orgName>
								<address>
									<settlement>Bolzano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Affiliated Institute of the University of Lübeck</orgName>
								<address>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Serena</forename><surname>Baratto</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">Paediatric Neurology and Muscle Disease Unit</orgName>
								<orgName type="institution">IRCCS Istituto Giannina Gaslini</orgName>
								<address>
									<settlement>Genova</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rosamaria</forename><surname>Silipigni</surname></persName>
							<affiliation key="aff4">
								<orgName type="laboratory">Laboratory of Medical Genetics</orgName>
								<orgName type="institution" key="instit1">Fondazione IRCCS Ca´Granda</orgName>
								<orgName type="institution" key="instit2">Ospedale Maggiore Policlinico</orgName>
								<address>
									<settlement>Milano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marina</forename><forename type="middle">Di</forename><surname>Segni</surname></persName>
							<affiliation key="aff4">
								<orgName type="laboratory">Laboratory of Medical Genetics</orgName>
								<orgName type="institution" key="instit1">Fondazione IRCCS Ca´Granda</orgName>
								<orgName type="institution" key="instit2">Ospedale Maggiore Policlinico</orgName>
								<address>
									<settlement>Milano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">P</forename><surname>Pramstaller</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute for Biomedicine</orgName>
								<orgName type="institution">Eurac Research</orgName>
								<address>
									<settlement>Bolzano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Affiliated Institute of the University of Lübeck</orgName>
								<address>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dario</forename><surname>Difrancesco</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elisabetta</forename><surname>Gazzerro</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">Paediatric Neurology and Muscle Disease Unit</orgName>
								<orgName type="institution">IRCCS Istituto Giannina Gaslini</orgName>
								<address>
									<settlement>Genova</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<orgName type="laboratory">Muscle Research Unit, Experimental and Clinical Research Center</orgName>
								<orgName type="institution">Charité University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Barbuti</surname></persName>
							<email>andrea.barbuti@unimi.it</email>
							<affiliation key="aff2">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>⁎⁎</roleName><forename type="first">Alessandra</forename><surname>Rossini</surname></persName>
							<email>alessandra.rossini@eurac.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Institute for Biomedicine</orgName>
								<orgName type="institution">Eurac Research</orgName>
								<address>
									<settlement>Bolzano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Affiliated Institute of the University of Lübeck</orgName>
								<address>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Institute for Biomedicine</orgName>
								<orgName type="institution">Eurac Research</orgName>
								<address>
									<addrLine>via Galvani 31</addrLine>
									<postCode>39100</postCode>
									<settlement>Bolzano</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Department of Biosciences</orgName>
								<orgName type="institution">Università degli Studi di Milano</orgName>
								<address>
									<addrLine>via Celoria 26</addrLine>
									<postCode>20133</postCode>
									<region>Milano</region>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Lab resource: Multiple cell lines Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-12-18">18 December 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">78DED22EF82DA757132F981E92C67118</idno>
					<idno type="DOI">10.1016/j.scr.2017.12.012</idno>
					<note type="submission">Received 27 November 2017 Received in revised form 14 December 2017 Accepted 16 December 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:42+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Caveolinopathies are a heterogeneous family of genetic pathologies arising from alterations of the caveolin-3 gene (CAV3), encoding for the isoform specifically constituting muscle caveolae.</s><s>Here, by reprogramming peripheral blood mononuclear cells, we report the generation of induced pluripotent stem cells (iPSCs) from three patients carrying the ΔYTT deletion, T78K and W101C missense mutations in caveolin-3.</s><s>iPSCs displayed normal karyotypes and all the features of pluripotent stem cells in terms of morphology, specific marker expression and ability to differentiate in vitro into the three germ layers.</s><s>These lines thus represent a human cellular model to study the molecular basis of caveolinopathies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Resource Table</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Unique stem cell lines identifier</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Resource utility</head><p><s>The established iPSC lines (EURACi001-A, EURACi002-A, EURACi003-A) provide a resource to generate in vitro human cardiomyocytes and myoblast/myotubes in order to understand the molecular and functional mechanisms leading to altered cellular excitability typical of these pathological CAV3 mutations and to evaluate a pharmacological approach to eventually correct such alterations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Resource details</head><p><s>The term caveolinopathies refers to a group of primary myopathies resulting from alteration of the proteins named caveolin-3, the main constituent of muscle caveolae.</s><s>These genetic disorders are mainly inherited through an autosomal dominant pattern.</s><s>The plasma membrane of cardiomyocytes is rich in caveolae and caveolins play multiple roles in the physiology of cardiovascular system <ref type="bibr" target="#b3">(Panneerselvam et al., 2012)</ref>.</s><s>Beyond its role in maintaining the structural integrity of caveolae, caveolin-3 is known to interact with several ion channels in the heart, modifying their functional properties and expression levels <ref type="bibr" target="#b0">(Barbuti et al., 2012;</ref><ref type="bibr" target="#b1">Campostrini et al., 2017)</ref>.</s><s>In order to elucidate in detail the role of CAV3 mutations in skeletal muscle and cardiac diseases, the availability of large quantities of human skeletal muscle and cardiac myocytes is a major requirement.</s><s>Since iPSC can be differentiated in both these cell types, they provide an unlimited source of human cells otherwise unavailable.</s><s>We generated iPSCs from three patients carrying different heterozygous mutations in CAV3 genes (Table <ref type="table" target="#tab_0">1</ref>): one patient who carries a deletion c.Δ184-192 (ΔYTT), one with c.303 TGG N TGC (W101C) mutation and another patient showing c.233 ACG N AAG (T78K) mutation.</s><s>At least four iPSC clones were generated from each patient and the iPSC clones (EURACi001-A, EURACi002-A, EURACi003-A) reported in this work were randomly selected and successfully characterized.</s><s>Specifically, iPSCs were obtained from peripheral blood mononuclear cells (PBMCs) using electroporation of episomal plasmids carrying OCT3/4, SOX2, KLF4, and L-MYC <ref type="bibr" target="#b2">(Meraviglia et al., 2015)</ref>.</s><s>iPSC colonies showed a typical human embryonic-stem cell morphology and were positive for alkaline phosphatase staining (Supplementary Fig. <ref type="figure" target="#fig_2">1A</ref>).</s><s>qRT-PCR analysis revealed that all iPSC lines expressed endogenous pluripotency genes (SOX2, OCT3, NANOG) at higher levels compared to their PBMCs counterpart (Supplementary Fig. <ref type="figure" target="#fig_2">1B</ref>).</s><s>Immunofluorescence analysis showed the expression of the pluripotency markers OCT4, SOX2 at nuclear level and SSEA4, TRA-1-60 as surface proteins (Fig. <ref type="figure" target="#fig_2">1A</ref>).</s><s>Flow cytometry allowed to quantify the percentage of cell positive for SSEA4 (≥ 97.8%) and SOX2 (≥ 79.8) in all the three iPSC lines (Fig. <ref type="figure" target="#fig_2">1B</ref>).</s><s>The ability of iPSC lines to differentiate into cells of the three germ layers following embryoid body (EB) formation was assessed by qPCR on endodermal (SOX7 and AFP in green), mesodermal (CD31, ACTA2, SCL and CDH5 in red) and ectodermal (KTR14, NCAM1, TH and GABRR2 in blue) genes (Fig. <ref type="figure" target="#fig_2">1C</ref>).</s><s>Furthermore, direct cardiomyogenic differentiation of all iPSC lines led to the formation of cardiomyocytes, as indicated by immunofluorescence staining of specific cardiac marker (α-Actinin), which displayed a clear sarcomeric pattern (Fig. <ref type="figure" target="#fig_2">1D</ref>).</s><s>Also, cytogenetic analysis was performed on all iPSC lines, showing a normal karyotype (Supplementary Fig. <ref type="figure" target="#fig_2">1C</ref>) and genomic DNA sequencing confirmed the presence of all the three mutations in CAV3 gene (Supplementary Fig. <ref type="figure" target="#fig_2">1D</ref>).</s><s>Then, STR analysis indicated that iPSCs and their PBMC counterparts yielded a match ≥ 98%, confirming that they are correctly derived from the donor (Table <ref type="table" target="#tab_1">2</ref>, data not shown).</s><s>Finally, PCR results indicated that all the iPSC lines were negative for mycoplasma contamination (Supplementary Fig. <ref type="figure" target="#fig_2">1E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.1.">Cell culture and reprogramming</head><p><s>PBMCs obtained from venous peripheral blood were amplified in suspension as previously described <ref type="bibr" target="#b2">(Meraviglia et al., 2015)</ref>.</s><s>5 × 10 6 PBMCs were reprogrammed by electroporation of 1 μg of each episomal vector (pCXLE-hOCT3/4-shp53-F, pCXLE-hSK, and pCXLE-hUL from Addgene) using Neon System (Thermo Fisher Scientific) following the program: 1650 V, 10 ms, 3 pulses.</s><s>Three days after electroporation, transfected PBMCs were plated on a feeder layer of irradiated mouse embryonic fibroblasts (MEFs) and cultured in iPSC medium containing knockout DMEM, 20% KO-Serum Replacement, 1 mM NEAAs, 1% Penicillin/Streptomycin, 1% L-Glutamine, 0.1 mM β-mercaptoethanol (all from Thermo Fisher Scientific) and 10 ng/ml bFGF (Merck-Millipore) <ref type="bibr" target="#b2">(Meraviglia et al., 2015)</ref>.</s><s>IPSCs maintained on MEFs were expanded by enzymatic dissociation using 1 mg/ml Collagenase IV (Thermo Fisher Scientific).</s><s>IPSCs adapted to feeder-free condition were cultured in TeSR-E8 medium (Stem Cell Technologies) on Matrigel matrix (Corning) and propagated using PBS-EDTA 0.5 mM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.2.">iPSC differentiation</head><p><s>For differentiation into the three germ layer, iPSCs on MEFs were detached and grown in ultra-low attachment plates for 7 days to form EBs in KO-DMEM (Thermo Fisher Scientific) with 20% FBS Defined (Hyclone), 1 mM NEAAs, 1% Penicillin/Streptomycin, 1% L-Glutamine, 0.1 mM β-mercaptoethanol (all from Thermo Fisher Scientific).</s><s>EBs were then plated onto 0.1% gelatin-coated dishes for further 10-15 days of differentiation.</s></p><p><s>Cardiomyogenic differentiation was performed on iPSC cultured in feeder free condition, plating 20,000 cells/cm 2 on 24-well plate coated with Matrigel and using PSC Cardiomyocyte Differentiation Kit (Thermo Fisher Scientific), according to manufacturer's instructions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.3.">Immunofluorescence staining</head><p><s>Pluripotency markers were detected using Pluripotent Stem Cell 4-Marker Immunocytochemistry Kit (Thermo Fisher Scientific) as indicated by manufacturer's instruction (Table <ref type="table">3</ref>).</s></p><p><s>After 35 days of differentiation, cardiomyocytes were fixed in PFA 4% for 10 min at room temperature.</s><s>Blocking of unspecific sites was achieved by incubation with 3% donkey serum in the presence of 0.3% Triton-X100 for 1 h at room temperature.</s><s>Primary antibodies were incubated overnight at 4 °C, while secondary antibodies were incubated 45 min at room temperature (Table <ref type="table">3</ref>).</s><s>Nuclei were stained with DAPI (Sigma-Aldrich).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.4.">Flow cytometry</head><p><s>Flow Cytometry analysis was performed using Multi-Color Flow Cytometry Kit (R&amp;D System) following manufacturer's instruction.</s><s>Samples were analyzed using FACSAriaII™ flow cytometry (BD Bioscience).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.5.">qRT-PCR</head><p><s>Total RNA from PBMCs, iPSCs and EBs was extracted using TRIzol® Reagent and 1 μg of RNA was reverse transcribed using SuperScript VILO cDNA Synthesis Kit following manufacturer's instruction (all from Thermo Fisher Scientific).</s><s>cDNA was amplified using All-in-One SYBR® Green qPCR Mix (GeneCopoeia) on CFX96 Real-Time PCR Detection System (BioRad).</s><s>Primers sequences were reported in Table <ref type="table">3</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.6.">Karyotiping</head><p><s>Cytogenetic Q-banding analysis was performed as previously described <ref type="bibr" target="#b2">(Meraviglia et al., 2015)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.7.">Sequencing and STR analysis</head><p><s>Genomic DNA from both iPSCs and corresponding PBMCs was sent to Eurofins Genomics (Germany) for analysis, according to ANSI/ATCC standard ASN-0002 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>In particular, 21 independent loci were investigated by PCR-single-locus-technology (Promega, PowerPlex 21 PCR Kit).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.8.">Mycoplasma test</head><p><s>The mycoplasma contamination test was carried out by PCR using primers able to recognize most of the Mycoplasma species (Table <ref type="table">3</ref>).</s></p><p><s>Supplementary data to this article can be found online at https://doi.</s><s>org/10.1016/j.scr.2017.12.012.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>EURACi001-A) September 2016 (EURACi002-A) https://doi.org/10.1016/j.scr.2017.12.012 1873-5061/© 2017 The Authors.</s><s>Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents lists available at ScienceDirect Stem Cell Research j o u r n a l h o m e p a g e : w w w .</s><s>e l s e v i e r .</s><s>c o m / l o c a t e / s c r</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>collected from patients after signing the informed consent provided by Cell Line and DNA Biobank from Patients Affected by Genetic Diseases, member of the Telethon Network of Genetic Biobanks, Istituto G. Gaslini, Genoa, Italy.</s><s>The generation and use of iPSCs was reviewed and approved by Ethical Committee at Universita' degli Studi di Milano (03.06.15, number 29/15).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Generation and characterization of three iPSC lines EURACi001-A, EURACi002-A and EURACi003-A.</s><s>(A) Immunofluorescence staining for pluripotency markers SSEA4, OCT4, SOX2 and TRA-1-60; scale bar 100 μm.</s><s>(B) Flow citometry analysis of pluripotency markers SSEA4 ad SOX2.</s><s>(C) Gene expression analysis of three germ layer markers after iPSC differentiation via embryoid body formation.</s><s>(D) Representative immunofluorescence images for sarcomeric protein α-Actinin after direct cardiomyogenic differentiation; scale bar 50 μm.</s></p></div></figDesc><graphic coords="3,44.79,53.18,514.54,382.56" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Summary of lines.</s></p></div></figDesc><table><row><cell>iPSC line names</cell><cell>Abbreviation in figures</cell><cell>Gender</cell><cell>Age</cell><cell>Ethnicity</cell><cell>Genotype of locus</cell><cell>Disease</cell></row><row><cell>EURACi001-A</cell><cell>EURACi001-A</cell><cell>Female</cell><cell>36</cell><cell>Caucasian</cell><cell>Het c.Δ184-192</cell><cell>Limb-girdle muscular dystrophy (LGMD-1C)</cell></row><row><cell>EURACi002-A</cell><cell>EURACi002-A</cell><cell>Female</cell><cell>22</cell><cell>Caucasian</cell><cell>Het c.303 TGG N TGC</cell><cell>Isolated Hyper-CKEmia</cell></row><row><cell>EURACi003-A</cell><cell>EURACi003-A</cell><cell>Female</cell><cell>43</cell><cell>Caucasian</cell><cell>Het c.233 ACG N AAG</cell><cell>Hyper-CKemia and Rippling Muscle Disease</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Characterization and validation.</s></p></div></figDesc><table><row><cell>Classification</cell><cell>Test</cell><cell>Result</cell><cell>Data</cell></row><row><cell>Morphology</cell><cell>Light miscroscopy</cell><cell>Normal morphology and alkaline phosphatase positivity</cell><cell>Supplementary Fig. 1A</cell></row><row><cell>Phenotype</cell><cell>Immunocytochemisty</cell><cell>Expression of pluripotency markers: SSEA4, OCT4, TRA-1-60,</cell><cell>Fig. 1A</cell></row><row><cell></cell><cell></cell><cell>SOX2</cell><cell></cell></row><row><cell></cell><cell>Flow cytometry</cell><cell>EURACi001-A positivity to:</cell><cell>Fig. 1B</cell></row><row><cell></cell><cell></cell><cell>SSEA4 99.9 ± 0.05%;</cell><cell></cell></row><row><cell></cell><cell></cell><cell>SOX2 = 96.4 ± 0.94%</cell><cell></cell></row><row><cell></cell><cell></cell><cell>EURACi002-A positivity to:</cell><cell></cell></row><row><cell></cell><cell></cell><cell>SSEA4 99.4% ± 0.19%;</cell><cell></cell></row><row><cell></cell><cell></cell><cell>SOX2 79.8% ± 7.56%</cell><cell></cell></row><row><cell></cell><cell></cell><cell>EURACi003-A positivity to:</cell><cell></cell></row><row><cell></cell><cell></cell><cell>SSEA4 97.8% ± 2.07%;</cell><cell></cell></row><row><cell></cell><cell></cell><cell>SOX2 88.0% ± 7.06%</cell><cell></cell></row><row><cell>Genotype</cell><cell>Karyotype (Q-banding)</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Resolution: 300-400 bands</cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">V.Meraviglia et al. / Stem Cell Research 27 (2018) 25-29   </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>This work was supported by Fondazione Cariplo (grant number 2014-1090) to Andrea Barbuti, Alessandra Rossini and Elisabetta Gazzerro and by the Department of Innovation, Research and Universities of the Autonomous Province of Bolzano-South Tyrol (Italy).</s></p><p><s>We thank "Cell Line and DNA Biobank from Patients Affected by Genetic Diseases", member of the Telethon Network of Genetic Biobanks (project no.</s><s>GTB12001), funded by Telethon Italy, for providing human samples.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins</title>
		<author>
			<persName><forename type="first">A</forename><surname>Barbuti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scavone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mazzocchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Terragni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baruscotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Difrancesco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Cell. Cardiol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="187" to="195" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability</title>
		<author>
			<persName><forename type="first">G</forename><surname>Campostrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bonzanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lissoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bazzini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Milanesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vezzoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Francolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baruscotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bucchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rivolta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Severi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cappato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Crotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Difrancesco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barbuti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc. Res</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="1256" to="1265" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Generation of induced pluripotent stem cells from frozen buffy coats using non-integrating episomal plasmids</title>
		<author>
			<persName><forename type="first">V</forename><surname>Meraviglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zanon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Lavdas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schwienbacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Silipigni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Segni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Pramstaller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Hicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rossini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Vis. Exp</title>
		<imprint>
			<date type="published" when="2015">2015. e52885</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Caveolins and heart diseases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Panneerselvam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Roth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Exp. Med. Biol</title>
		<imprint>
			<biblScope unit="volume">729</biblScope>
			<biblScope unit="page" from="145" to="156" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
